Four insights:
1. Researchers polymerized estrogen into a slow-releasing biomaterial to protect nervous system cells and promote regeneration.
2. The polymer targeted injured tissue and emitted estrogen as a therapeutic over a period of years when implanted on the spinal cord.
3. The researchers used a photo-triggered chemical process to synthesize the estrogen into polymer chains that were spun into fibers for spinal cord implantation.
4. Researchers are eyeing preclinical testing, where they can explore how their polymerized fibers would work in a living system.
More articles on biologics:
7 big moves for Hospital for Special Surgery in 2019
5 highest paying physician specialties — Neurosurgeon No. 1 at $401k
Dr. Thomas Loftus: How a single-payer system would harm spine practice in the US
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
